Anti-il-1β antibody
3 papers3 findings
- 2 independent labs in 2 countries
- Funders: Fondation Leducq and 4 more
- Humans1
- Animals1
Outcomes
3Sepsis symptoms
downin mice1
1 study
Sepsis symptoms
downin mice1
Anti-il-1β antibody decreases sepsis symptoms in mice.
“Treatment with NLRP3 inhibition (MCC950) and antibodies against IL-18 and IL-1β alleviated sepsis symptoms in aged mice”
Animalscecal ligation and puncture-induced sepsis
Life sciencesJun 16, 2025
Cellular senescence
upin mice1
1 study
Cellular senescence
upin mice1
Anti-il-1β antibody increases cellular senescence in mice.
“increasedintraplaque hemorrhage, necrotic core area, and senescence as compared with IgG control antibody-treated mice.”
Animalsafter diet-induced reductions in lipids in Apoe-/- mice8 weeks
Arteriosclerosis, thrombosis, and vascular biologyMay 2, 2024
Atherosclerotic plaque burden
upin mice1
1 study
Atherosclerotic plaque burden
upin mice1
Anti-il-1β antibody increases atherosclerotic plaque burden in mice.
“IL-1β antibody treatment after diet-induced reductions in lipids resulted in multiple detrimental changes including increased plaque burden and brachiocephalic artery lesion size”
Animalsafter diet-induced reductions in lipids in Apoe-/- mice8 weeks
Arteriosclerosis, thrombosis, and vascular biologyMay 2, 2024
Latest
Arteriosclerosis, Thrombosis, and Vascular Biology
IL-1β Inhibition Partially Negates the Beneficial Effects of Diet-Induced Atherosclerosis Regression in Mice
Experiments in miceAtherosclerosis
European Journal of Pharmacology
Research progress of NLRP3 inflammasome and its inhibitors with aging diseases
ReviewInterventions